The overarching goals of the lab are to accelerate the identification of novel therapeutic targets for human diseases by leveraging chemical biology tools and multi-omic human datasets.
Boston, Mass. — Deaths from treatable conditions may cost the world trillions of dollars each year, according to a newly published analysis led by Harvard Medical School researchers believed to be the first to quantify the economic impact of insufficient access to high-quality medical care. The...
New Findings in Dystonia - Dr. Simonyan's research is highlighted in the Spring 2018 issue of Harvard Otolaryngology. “Continuation of [dystonia] research is vital in determining the exact causes and mechanisms of this disorder. This knowledge will be crucial for the future development of novel...
Thirty-two Harvard Ophthalmology/Mass. Eye and Ear clinical trainees graduated on June 21. The ceremony, held at Mass. Eye and Ear, celebrated eight Harvard Ophthalmology residents, the AY 2017-2018 chief resident, and two optometry residents, as well as 21 clinical fellows from Mass. Eye and Ear...
Our lab integrates multiple complementary approaches, including: genetic discovery in human cohorts, genome editing in zebrafish and human cell models, mass spectrometry–based metabolite profiling, and high-throughput screening of small-molecule libraries. We apply these strategies across several...